HETERO LABS LIMITED
Location
Telangana
Founded
1989-03-10
Website
Risk Signals
263 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about HETERO LABS LIMITED
Live alerts from global media, monitored by Business Radar
2023-04-24 (expresspharma.in)
Sun Pharma, Hetero recall drugs in US
Sun Pharma is recalling a generic drug indicated to raise blood pressure in adults while Hetero Labs is recalling a drug used to treat certain stomach and oesophagus problems
Read more
2019-09-23 (outsourcing-pharma.com)
Torrent expands recall of losartan products, again
Torrent announces that it will recall batches of losartan tablets for the sixth time, after the detection of NMBA exceeding acceptable daily intake levels in latest recall.
Read more
2019-06-11 (miamiherald.com)
Torrent Pharmaceuticals recalls 5 lots of losartan potassium
Torrent Pharmaceuticals recalls five lots of heart and blood pressure medication losartan after finding “unexpected impurity” NMBA in the active ingredient made by Hetero Labs Limited.
Read more
2019-03-19 (nrc.nl)
Cancer-causing pollution in blood pressure medicine again
Contaminated medicines: The Inspectorate recalls contaminated losartan pills from 16,000 patients in the Netherlands. Last month it turned out that millions worldwide…
Read more
2019-03-04 (taipeitimes.com)
FDA recalls blood pressure drugs over cancer doubts
The Food and Drug Administration (FDA) has ordered that two generic blood pressure drugs be removed from shelves, after its US counterpart found new potentially carcinogenic impurities in them.
Read more
2019-01-14 (usatoday.com)
Blood pressure drug recall: FDA investigates foreign plants that made drugs with cancer-causing impurities
The FDA increased inspections of foreign drugmakers. Problems remain at Chinese and Indian plants that made blood pressure meds recalled for cancer risk.
Read more
(pharmaceutical-business-review.com)
Teva Pharmaceuticals USA recalls Losartan Potassium 25mg and 100mg Tablets USP sold exclusively to Golden State Medical Supply - Pharmaceutical Business review
This recall is due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – found in six lots of active pharmaceutical ingredient (API) manufactured by Hetero Labs
Read more
(fiercepharma.com)
With Teva and Torrent, recalls of tainted losartan now add up to 368 lots
There is more fallout from tainted losartan API produced in India by Hetero Labs. | There is more fallout from tainted losartan API produced in India by Hetero Labs. A week after Torrent recalled more than 100 lots because of an impurity that might cause cancer, Teva has added to the recall with 35 lots of bulk losartan potassium tablets made with the Hetero ingredient. The two recalls will likely deepen shortages of losartan that the FDA has already warned of.
Read more
(precisionvaccinations.com)
Valsartan-Containing Product Recall Expanded by FDA
Camber Pharmaceuticals Inc. valsartan-containing products produced by Hetero Labs recalled
Read more